SKCC Researchers Investigate Tumor-Immune Cell Crosstalk in Aggressive Form of Prostate Cancer | Jefferson Health
Prostate cancer is the second most commonly diagnosed cancer among men worldwide. Researchers at the Sidney Kimmel Cancer Center – Jefferson Health (SKCC) are working to better understand neuroendocrine prostate cancer (NEPC), a particularly aggressive form of the disease that arises after the initial treatment of prostate cancer.